| Product dosage: 0.3mg | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 1 | $60.20 | $60.20 (0%) | 🛒 Add to cart |
| 2 | $50.17 | $120.40 $100.34 (17%) | 🛒 Add to cart |
| 3 | $43.48 | $180.61 $130.44 (28%) | 🛒 Add to cart |
| 4 | $42.64 | $240.81 $170.57 (29%) | 🛒 Add to cart |
| 5 | $40.13 | $301.01 $200.67 (33%) | 🛒 Add to cart |
| 6 | $38.46 | $361.21 $230.78 (36%) | 🛒 Add to cart |
| 7 | $37.27 | $421.42 $260.88 (38%) | 🛒 Add to cart |
| 8 | $36.37 | $481.62 $290.98 (40%) | 🛒 Add to cart |
| 9 | $34.56 | $541.82 $311.04 (43%) | 🛒 Add to cart |
| 10 | $33.11
Best per bottle | $602.02 $331.11 (45%) | 🛒 Add to cart |
Synonyms | |||
More info:
bimat
Bimat represents one of those rare convergence points where surgical innovation meets pharmacological advancement - a prostaglandin analogue ophthalmic solution that’s fundamentally changed how we manage glaucoma and ocular hypertension. When I first encountered it during my fellowship at Wilmer Eye Institute back in 2008, we were still heavily reliant on beta-blockers and carbonic anhydrase inhibitors with their systemic side effect profiles. The introduction of bimatoprost 0.03% solution marked a paradigm shift in our approach to intraocular pressure management.
careprost
Careprost is an ophthalmic solution containing bimatoprost 0.03% as its active pharmaceutical ingredient. It’s classified as a prostaglandin analog and represents one of the most significant advances in glaucoma management and cosmetic eyelash enhancement over the past two decades. Originally developed for intraocular pressure reduction, its secondary effect on eyelash growth created an entirely new therapeutic application that continues to evolve in clinical practice. Careprost: Effective Eyelash Enhancement and Glaucoma Management - Evidence-Based Review 1.
lumigan
Lumigan, known generically as bimatoprost ophthalmic solution 0.03%, represents one of the more fascinating developments in glaucoma management over the past two decades. Initially discovered somewhat serendipitously during prostaglandin analog research for other indications, this clear, sterile topical solution has fundamentally changed how we approach intraocular pressure reduction in clinical practice. What began as an eyelash growth side effect observation eventually became its own FDA-approved product (Latisse), but the primary application remains glaucoma and ocular hypertension management.
xalatan
Latanoprost ophthalmic solution, marketed under the brand name Xalatan among others, represents one of the most significant advances in glaucoma management since the introduction of beta-blockers. As a prostaglandin analog, its mechanism of action fundamentally changed how we approach intraocular pressure reduction, offering efficacy with once-daily dosing and a generally favorable side effect profile. I remember when it first came to our clinic - we were skeptical about switching patients from their established timolol regimens, but the data was compelling.
Abana: Comprehensive Cardiovascular Support Through Ayurvedic Medicine - Evidence-Based Review
Product Description: Abana is an Ayurvedic herbal formulation primarily used in cardiovascular health management. It’s one of those interesting supplements that bridges traditional medicine and modern cardiology practice - we’ve been using it in our integrative cardiology clinic for about 15 years now, and the results have been… well, let’s just say more nuanced than the marketing materials suggest. 1. Introduction: What is Abana? Its Role in Modern Medicine When patients first ask me “what is Abana,” I usually start by explaining it’s not a single herb but rather a sophisticated polyherbal formulation that’s been used in Ayurvedic medicine for centuries.
Abhigra: Advanced Neuro-Endocrine Support for Stress Adaptation - Evidence-Based Review
Before we dive into the formal monograph, let me give you the real story behind Abhigra. We initially developed it as a specialized anti-inflammatory matrix for post-surgical recovery, but our first pilot study with orthopedic patients showed something unexpected – the most significant improvements were actually in mood stabilization and sleep architecture. Dr. Chen from our team was convinced we’d contaminated the samples, but the cortisol and cytokine panels didn’t lie.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily block dopamine D2 receptors, aripiprazole functions as a partial dopamine agonist - a mechanism that both stimulates and blocks dopamine receptors depending on the brain’s dopamine levels. This unique pharmacological profile has positioned it as a versatile treatment option across multiple psychiatric conditions, from schizophrenia and bipolar disorder to adjunctive treatment for major depressive disorder.
Acamprol: Effective Alcohol Craving Reduction and Relapse Prevention - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story on Acamprol. I’ve been working with this compound for nearly a decade now, back when it was still coded as CAM-1187 in development. The initial premise was simple: create a safer alternative to benzodiazepines for alcohol withdrawal that didn’t carry the same dependency risks. What we discovered along the way was much more complex and frankly, more interesting than any of us anticipated.
accufine
Product Description: Accufine represents a significant advancement in non-invasive glucose monitoring technology. This compact wearable device uses multi-spectral sensor fusion and proprietary algorithms to provide continuous interstitial glucose readings without the need for fingerstick calibration. The system consists of a discreet, water-resistant sensor patch applied to the upper arm and a companion smartphone application that displays real-time glucose trends, predictive alerts, and comprehensive data analytics. What sets Accufine apart isn’t just the technology itself, but how it’s transformed the daily experience for people living with diabetes - something I’ve witnessed repeatedly in my endocrine practice over the past three years.